From: Off-label indications for atypical antipsychotics: A systematic review
Jadad Index > 2 (N = 10) | Â | Â | Â | Â | Â | Â | Â |
---|---|---|---|---|---|---|---|
 | N of papers | Year | Jadad Index | P N W | N of patients | Financial support | Drug dose (mg/day) |
Risperidone (N = 7) | Â | Â | Â | Â | Â | Â | Â |
Substance abuse | 1 | 2000 | 3 | 0 1 0 | 125 | I | 2–8 |
OCD | 1 | 2000 | 5 | 1 0 0 | 36 | I | 2.2 |
Pervasive Developmental disorder | 3 | 1998, 2001, 2001 | 5, 3, 3 | 3 0 0 | 31, 38, 13 | I, P, P | 2.9, 2.9, 1.2 |
Stuttering | 1 | 1999 | 3 | 1 0 0 | 21 | I | <2 |
Tourette's syndrome | 1 | 2001 | 5 | 1 0 0 | 50 | P | 3.8 |
Olanzapine (N = 3) | Â | Â | Â | Â | Â | Â | Â |
Depression | 1 | 2001 | 3 | 1 0 0 | 28 | P | 12.5–13.5 |
Personality disorder | 1 | 2001 | 5 | 1 0 0 | 28 | P | 5.33 |
Post Traumatic Stress disorder | 1 | 2001 | 3 | 0 1 0 | 15 | P | 14.1 |
Quetiepine (N = 0) | 0 | - | - | - | - | - | - |